444

BIOPTIK TECH INC

No trades
See on Supercharts
Market capitalization
‪1.59 B‬TWD
1.95TWD
‪85.71 M‬TWD
‪828.50 M‬TWD
‪45.44 M‬
Beta (1Y)
0.43

About BIOPTIK TECH INC


CEO
Chin Chang Yang
Headquarters
Miaoli
Founded
1999
ISIN
TW0004161005
FIGI
BBG001WV6HW4
Bioptik Technology, Inc. engages in the research and development, manufacture, and sale of hyaluronic acid and skincare product. Its products include monitoring systems for blood glucose, uric acid and cholesterol. The company was founded on June 1, 1999 and is headquartered in Miaoli, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4161 is 32.80 TWD — it has increased by 0.46% in the past 24 hours. Watch BIOPTIK TECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange BIOPTIK TECH INC stocks are traded under the ticker 4161.
4161 stock has fallen by −1.20% compared to the previous week, the month change is a −6.94% fall, over the last year BIOPTIK TECH INC has showed a 8.61% increase.
4161 reached its all-time high on Oct 7, 2014 with the price of 118.05 TWD, and its all-time low was 17.50 TWD and was reached on Dec 20, 2011. View more price dynamics on 4161 chart.
See other stocks reaching their highest and lowest prices.
4161 stock is 0.61% volatile and has beta coefficient of 0.43. Track BIOPTIK TECH INC stock price on the chart and check out the list of the most volatile stocks — is BIOPTIK TECH INC there?
Today BIOPTIK TECH INC has the market capitalization of ‪1.73 B‬, it has decreased by −0.76% over the last week.
Yes, you can track BIOPTIK TECH INC financials in yearly and quarterly reports right on TradingView.
4161 net income for the last quarter is ‪18.03 M‬ TWD, while the quarter before that showed ‪28.84 M‬ TWD of net income which accounts for −37.47% change. Track more BIOPTIK TECH INC financial stats to get the full picture.
BIOPTIK TECH INC dividend yield was 2.18% in 2023, and payout ratio reached 41.60%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOPTIK TECH INC EBITDA is ‪140.40 M‬ TWD, and current EBITDA margin is 15.05%. See more stats in BIOPTIK TECH INC financial statements.
Like other stocks, 4161 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOPTIK TECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOPTIK TECH INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOPTIK TECH INC stock shows the sell signal. See more of BIOPTIK TECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.